By Dawood Fakhir ( November 6, 2025, 4:47 PM GMT) -- Biotechnology company Allergy Therapeutics, which is listed on the junior investment market of the London Stock Exchange, said Thursday that it's planning a dual primary listing of its shares on the Hong Kong Stock Exchange to expand its presence in Asia....

See Full Page